![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
2028년까지 유럽 혈장 분획 시장 예측 - 제품별(면역글로불린, 알부민, 응고 인자 농축물, 프로테아제 억제제 및 기타 혈장 제품), 응용 분야(신경학, 면역학, 혈액학, 중환자 치료, 폐학 및 기타)별 코로나19 영향 및 지역 분석 응용 프로그램) 및 최종 사용자(병원 및 진료소, 임상 연구 실험실 및 학술 기관)Â Â Â Â Â Â
시장 소개
유럽 혈장 분획 시장에는 독일, 프랑스, 영국, 스페인, 이탈리아 및 기타 유럽 지역. 유럽은 전 세계 혈장 분획 시장에서 중요한 위치를 차지하고 있으며 예측 기간 동안 견고한 성장률을 기록할 것으로 추정됩니다. 인구 노령화, 다양한 만성 질환 치료를 위한 면역글로불린 사용 증가, 면역 및 출혈 장애 유병률 증가, 질병 관리를 위한 혈장 치료법 급증으로 인해 이 지역의 시장 성장이 모두 유럽 지역의 시장 성장을 주도할 것으로 예상됩니다. 예측 기간.
유럽 국가에서는 신경 질환, 혈액 질환, 호흡기 질환 등 다양한 만성 질환의 의료 관행이 변화했습니다. 의료진의 다양화와 중증환자 치료에 집중하기로 한 결정으로 인해 코로나19의 증가는 질병 발견 및 치료에 영향을 미쳤습니다. 현재의 팬데믹으로 인해 많은 연구 기관에서는 코로나19 연구에 더 집중하고 있으며 바이러스를 더 잘 이해하기 위해 열심히 노력하고 있습니다. 이 지역의 일부 연방 기관은 코로나19 환자를 치료하기 위해 혈장 치료법을 채택하는 데 앞장섰습니다. 예를 들어, 프랑스 국립 의약품 및 건강 제품 안전청(ANSM)은 중증 환자 치료에 면역 혈장 치료법을 사용할 것이라고 발표했습니다. 또한 유럽연합 집행위원회는 중환자 치료를 위해 회복기 혈장 요법의 긴급 사용을 권장했습니다. 따라서 코로나19 관리에 혈장 치료법을 사용하는 것은 시장에 어느 정도 긍정적인 영향을 미쳤습니다. 그러나 코로나19로 인해 신경질환, 혈액질환, 특이질환 등 전반적인 의료 관행이 변화하고 있으며, 대다수의 제약·바이오제약사들이 코로나19에 대한 새로운 치료법 개발을 강조하고 있으며, 이는 코로나19에 부정적인 영향을 미치고 있다. 시장 성장.
< p>시장 개요 및 역학유럽의 혈장 분획 시장 2021년 68억 2467만 달러에서 2028년 104억 295만 달러로 성장할 것으로 예상된다. 2021년부터 2028년까지 CAGR 6.2%로 성장할 것으로 예상됩니다. 노인 인구 증가, 신경학, 혈액학, 희귀 유전 질환 및 자가면역 질환 등 다양한 치료 분야에서 면역글로불린의 사용이 증가하고 관리를 위한 혈장 유래 치료법에 대한 수요도 증가하고 있습니다. 의 질병은 모두 나머지 유럽 지역의 혈장 분획 시장을 활성화할 것으로 예상됩니다. 또한, 유럽의 다양한 기업들은 질병 관리를 위한 혈장 치료법의 새로운 접근법을 개발하고 출시하기 위해 연구 개발 활동에 더 많은 투자를 하고 있습니다.
주요 시장 부문
유럽 혈장 분획 시장은 제품, 애플리케이션, 최종 사용자 및 국가로 분류됩니다. 유럽 혈장 분획 시장은 제품을 기준으로 면역글로불린, 알부민, 응고 인자 농축물, 프로테아제 억제제 등으로 분류되었습니다. 면역글로불린 부문은 2021년 시장에서 가장 큰 점유율을 차지할 것으로 보입니다. 응용 분야에 따라 유럽 혈장 분획 시장은 신경학, 면역학, 혈액학, 중환자 치료, 폐질환 등으로 분류됩니다. 2021년에는 신경학 부문이 시장에서 가장 큰 점유율을 차지할 가능성이 높습니다. 최종 사용자를 기반으로 하는 유럽 혈장 분획 시장은 병원, 진료소, 임상 연구 실험실, 학술 기관으로 분류됩니다. 2021년에는 병원 및 진료소 부문이 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다. 국가를 기준으로 유럽 혈장 분획 시장은 프랑스, 독일, 이탈리아, 스페인, 영국 및 기타 유럽 지역으로 분류됩니다. 나머지 유럽 지역은 2021년에 가장 큰 시장 점유율을 차지했습니다.
등재된 주요 출처 및 회사
유럽 혈장 분획 시장에 대한 이 보고서를 준비하는 데 참조된 몇 가지 주요 1차 및 2차 소스로는 회사 웹사이트, 연례 보고서, 재무 보고서, 국가 정부 문서, 통계 데이터베이스 등이 있습니다. 보고서에 나열된 주요 회사는 Bharat Serums and Vaccines Limited(BSV)입니다. 바이오프로덕츠연구소(Bio Products Laboratory Ltd.); 바이오테스트 AG; CSL 제한; 그리폴스, SA; 케드리온 SpA; 옥타파마AG; 산퀸; 그리고 SK플라즈마.
구매 이유 보고서 span>
- 유럽 혈장 분획 시장 환경을 이해하고 다음을 보장할 가능성이 가장 높은 시장 부문을 식별합니다. 강력한 수익을 거두십시오.
- 유럽 혈장 분획 시장의 끊임없이 변화하는 경쟁 환경을 이해하여 경쟁에서 앞서 나가십시오.
- 가장 유망한 판매 가능성이 있는 시장 부문을 식별하여 유럽 혈장 분획 시장에서 M&A 및 파트너십 거래를 효율적으로 계획합니다.
- 유럽 혈장 분획 시장의 다양한 부문의 시장 성과.
- 2021~2028년 유럽 지역의 다양한 부문별 시장 수익 예측을 확인하세요.
유럽 혈장 분획 시장 세분화
유럽 혈장 분획 시장 - 제품별
- 면역글로불린
- 정맥 면역글로불린(IVIG)
- 피하 면역글로불린(SCIG)
- 알부민
- 응고인자 농축물
- 프로테아제 억제제
- 기타
유럽 혈장 분획 시장 - 기준 응용
- 신경학
- 면역학
- 혈액학
- 중환자 치료
- 폐렴학
- 기타
유럽 플라즈마 분별 시장 - 최종 사용자별
- 병원 및 진료소
- 임상 연구 실험실
- 학술 기관
유럽 혈장 분획 시장 - 국가별
- 프랑스
- 독일
- 이탈리아
- 스페인
- 영국
- 유럽 나머지 지역
유럽 혈장 분획 시장 - 회사 프로필
- Bharat Serums and Vaccines Limited(BSV)
- Bio Products Laboratory Ltd.
- Biotest AG.
- CSL Limited
- Grifols, SA
- Kedrion SpA
- Octapharma AG
- 산퀸
- SK플라즈마
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Plasma Fractionation Market – By Product
1.3.2 Europe Plasma Fractionation Market – By Application
1.3.3 Europe Plasma Fractionation Market – By End User
1.3.4 Europe Plasma Fractionation Market – By Country
2. Europe Plasma Fractionation Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Plasma Fractionation Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Plasma Fractionation Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Plasma Therapy Being Widely Used
5.1.2 Market is Developing Due to Active Participation of the Key Players
5.2 Market Restraints
5.2.1 Alternate Non-Plasma Substitutes Available
5.3 Future Trends
5.3.1 Novel Diseases Getting Treated By Using Plasma Therapy
5.4 Impact Analysis
6. Plasma Fractionation Market – Europe Analysis
6.1 Europe Plasma Fractionation Market Revenue Forecast and Analysis
7. Europe Plasma Fractionation Market Revenue and Forecasts To 2028– by Product
7.1 Overview
7.2 Europe Plasma Fractionation Market, By Product 2021 & 2028 (%)
7.3 Immunoglobulin
7.3.1 Overview
7.3.2 Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.1 Intravenous Immunoglobulin (IVIG)
7.3.2.1.1 Overview
7.3.2.1.2 Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.2 Subcutaneous Immunoglobulin (SCIG)
7.3.2.2.1 Overview
7.3.2.2.2 Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Albumin
7.4.1 Overview
7.4.2 Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Coagulation Factor Concentrates
7.5.1 Overview
7.5.2 Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Protease Inhibitors
7.6.1 Overview
7.6.2 Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.7 Other Plasma Products
7.7.1 Overview
7.7.2 Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
8. Europe Plasma Fractionation Market Revenue and Forecasts To 2028 – Application
8.1 Overview
8.2 Europe Plasma Fractionation Market Share by Application 2021 & 2028 (%)
8.3 Neurology
8.3.1 Overview
8.3.2 Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Immunology
8.4.1 Overview
8.4.2 Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Hematology
8.5.1 Overview
8.5.2 Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Critical Care
8.6.1 Overview
8.6.2 Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Pulmonology
8.7.1 Overview
8.7.2 Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Other Applications
8.8.1 Overview
8.8.2 Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9. Europe Plasma Fractionation Market Revenue and Forecasts To 2028 – End User
9.1 Overview
9.2 Europe Plasma Fractionation Market Share by End User 2021 & 2028 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Clinical Research Laboratories
9.4.1 Overview
9.4.2 Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Academic Institutes
9.5.1 Overview
9.5.2 Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
10. Europe Plasma Fractionation Market Revenue and Forecasts to 2028 – Country Analysis
10.1 Overview
10.1.1 Europe: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
10.1.1.1 Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Germany: Plasma Fractionation Market, by Product– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3.1 Germany: Plasma Fractionation Market, by Immunoglobulin Type– Revenue and Forecast to 2028 (USD Million)
10.1.1.1.4 Germany: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.5 Germany: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 France: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3.1 France: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.4 France: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.5 France: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 UK: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3.1 UK: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.4 UK: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.5 UK: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4 Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Spain: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3.1 Spain: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.4 Spain: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.5 Spain: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5 Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Italy: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3.1 Italy: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.4 Italy: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.5 Italy: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6 Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Europe: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3.1 Rest of Europe: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.4 Rest of Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.5 Rest of Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Europe Plasma Fractionation Market
11.1 Europe: Impact Assessment Of COVID-19 Pandemic
12. Plasma Fractionation Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Followed by Major Market Players (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic developments
12.4.1 Overview
13. Company Profiles
13.1 Biotest AG.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Octapharma AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Kedrion S.p.A
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 CSL Limited
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Grifols, S.A.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bio Products Laboratory Ltd.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Sanquin
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Bharat Serums and Vaccines Limited (BSV)
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 SK Plasma
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Plasma Fractionation Market, by Immunoglobulin Type– Revenue and Forecast to 2028 (USD Million)
Table 3. Germany: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. France: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 6. France: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 7. France: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. France: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. UK: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 10. UK: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 11. UK: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. UK: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Spain: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 14. Spain: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 15. Spain: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Spain: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 19. Italy: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20. Italy: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of Europe: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Europe: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. Organic Developments Done By Companies
Table 26. Inorganic developments done by Companies
Table 27. Glossary of Terms, Plasma Fractionation Market
LIST OF FIGURES
Figure 1. Europe Plasma Fractionation Market Segmentation
Figure 2. Europe Plasma Fractionation Market Segmentation, By Country
Figure 3. Europe Plasma Fractionation Market Overview
Figure 4. Immunoglobulin Segment Held the Largest Share of the Product Segment in Europe Plasma Fractionation Market
Figure 5. Germany to Show Significant Growth During Forecast Period
Figure 6. Europe and PEST Analysis
Figure 7. Impact Analysis of Drivers and Restraints Pertaining to Europe Plasma Fractionation Market
Figure 8. Europe Plasma Fractionation Market – Revenue Forecast and Analysis – 2019- 2028
Figure 9. Europe Plasma Fractionation Market, by Product 2021 & 2028 (%)
Figure 10. Europe Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. Europe Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. Europe Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. Europe Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. Europe Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. Europe Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 16. Europe Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. Europe Plasma Fractionation Market Share by Application 2021 & 2028 (%)
Figure 18. Europe Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 19. Europe Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 20. Europe Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 21. Europe Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 22. Europe Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 23. Europe Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 24. Europe Plasma Fractionation Market Share by End User 2021 & 2028 (%)
Figure 25. Europe Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 26. Europe Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 27. Europe Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 28. Europe: Plasma Fractionation Market, by Key Country – Revenue (2021) (USD Million)
Figure 29. Europe: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
Figure 30. Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 33. Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 34. Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 35. Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 36. Impact of COVID-19 Pandemic in European Country Markets
Figure 37. Growth Strategies Followed by Major Market Players (%)- Bharat Serums and Vaccines Limited (BSV)
- Bio Products Laboratory Ltd.
- Biotest AG.
- CSL Limited
- Grifols, S.A.
- Kedrion S.p.A
- Octapharma AG
- Sanquin
- SK Plasma
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe plasma fractionation market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Europe plasma fractionation market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the plasma fractionation market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution